Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: The potential and the questions
- 31 August 2003
- journal article
- review article
- Published by Elsevier in Surgical Clinics of North America
- Vol. 83 (4) , 943-971
- https://doi.org/10.1016/s0039-6109(03)00071-9
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Taxanes in the Adjuvant Treatment of Breast Cancer: Why Not Yet?JNCI Monographs, 2001
- Taxanes in the Treatment of Breast Cancer: A Prodigy Comes of AgeCancer Investigation, 1999
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Docetaxel.Journal of Clinical Oncology, 1995
- Paclitaxel (TaxolTM) and docetaxel (TaxotereTM): Not simply two of a kindAnnals of Oncology, 1994
- Relationships between the structure of taxol analogs and their antimitotic activityJournal of Medicinal Chemistry, 1991
- Studies With RP 56976 (Taxotere): A Semisynthetic Analogue of TaxolJNCI Journal of the National Cancer Institute, 1991
- Application of the vicinal oxyamination reaction with asymmetric induction to the hemisynthesis of taxol and analoguesTetrahedron, 1989
- Promotion of microtubule assembly in vitro by taxolNature, 1979
- Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifoliaJournal of the American Chemical Society, 1971